A2PP inhibits <i>M</i>. <i>hyorhinis</i> infection.

(A) Western blotting of p37 from AGS and BGC823 cells infected with 105 CCU/ml of M. hyorhinis and treated with A2PP (20 μM), CIP (4 μg/ml), MYCO I (5 μg/ml), or MYCO II (10 μg/ml) for 24 hr. Mean ± SD from 3 independent experiments. (B) qPCR analysis of p37 in AGS and BGC823 cells treated as in (A). Mean ± SD from 3 experiments with triplicate for each sample. (C) Western blotting of p37 from AGS cells infected with 105 CCU/ml of M. hyorhinis and treated with A2PP in the process of cell passages from P1 to P3. Mean ± SD from 3 independent experiments. (D) qPCR analysis of p37 in AGS cells infected and treated as in (C). Mean ± SD from 3 experiments with triplicate samples. **, P < 0.01; ***, P < 0.001; ns, no significance.